1-15 of 949
Recognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Heart MattersRecognizing ATTR-CA in Cardioembolic Stroke: Emerging Diagnostic Clues
Exploring Deeper Silencing in Transthyretin Amyloidosis
AudioAbstractsExploring Deeper Silencing in Transthyretin Amyloidosis
Ryan Quigley
How Symptoms Shape Caregiver Burden in ATTR-CM
AudioAbstractsHow Symptoms Shape Caregiver Burden in ATTR-CM
Ryan Quigley
Bridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Conversations in CV Risk AssessmentBridging the Gap: From Screening to Cardiovascular Risk Diagnosis
Jennifer Caudle, DO, FACOFP
Dustin Le, MD, MHS
Niloo Nobakht, MD, FASN
Early Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Heart MattersEarly Recognition of ATTR-CM: Key Signs and Diagnostic Strategies
Valmiki Maharaj, MD
- advertisement
Ronald Witteles, MD
Early Detection of ATTR-CM: Clinical Clues and Imaging Approaches
On the Frontlines of ATTR-CMEarly Detection of ATTR-CM: Clinical Clues and Imaging Approaches
Shelina Ramnarine, PhD
Valmiki Maharaj, MD
Recognizing and Managing Swelling in ATTR-CM
On the Frontlines of ATTR-CMRecognizing and Managing Swelling in ATTR-CM
Steve Jackson, PharmD
Kevin S. Shah, MD
Understanding Real-World Testing Patterns in ATTR-CM
On the Frontlines of ATTR-CMUnderstanding Real-World Testing Patterns in ATTR-CM
Steve Jackson, PharmD
Ronald Witteles, MD
Recognizing ATTR-CM in High-Risk Populations
On the Frontlines of ATTR-CMRecognizing ATTR-CM in High-Risk Populations
Steve Jackson, PharmD
Frederick Ruberg, MD
HCM vs HFpEF: Avoiding Common Diagnostic Pitfalls
CardiologyHCM vs HFpEF: Avoiding Common Diagnostic Pitfalls
Ahmad Masri, MD, MS
- advertisement
Understanding the Mechanisms Behind Resistant Hypertension
Heart MattersUnderstanding the Mechanisms Behind Resistant Hypertension
Steve Jackson, PharmD
Jan Basile, MD
Michael J. Bloch, MD, FAHA, FASH, FNLA, FSVM, FACP
The Risk Equation: Combining uACR and eGFR for CV Prediction
Conversations in CV Risk AssessmentThe Risk Equation: Combining uACR and eGFR for CV Prediction
Matthew Sorrentino, MD
Ashish Verma, MBBS
Albuminuria: An Overlooked Red Flag in Cardiovascular Risk
Conversations in CV Risk AssessmentAlbuminuria: An Overlooked Red Flag in Cardiovascular Risk
Matthew Sorrentino, MD
Ashish Verma, MBBS
